- Home
- ACXP vs SXTP Comparison
ACXP vs SXTP Comparison
Compare ACXP & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- SXTP
- Stock Information
- Founded
- ACXP 2017
- SXTP 2010
- Country
- ACXP United States
- SXTP United States
- Employees
- ACXP N/A
- SXTP N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- ACXP Health Care
- SXTP Health Care
- Exchange
- ACXP Nasdaq
- SXTP Nasdaq
- Market Cap
- ACXP 6.8M
- SXTP 6.7M
- IPO Year
- ACXP 2021
- SXTP 2023
- Fundamental
- Price
- ACXP $6.30
- SXTP $1.42
- Analyst Decision
- ACXP Strong Buy
- SXTP Buy
- Analyst Count
- ACXP 3
- SXTP 2
- Target Price
- ACXP $143.67
- SXTP $3.00
- AVG Volume (30 Days)
- ACXP 1.6M
- SXTP 285.4K
- Earning Date
- ACXP 11-12-2025
- SXTP 11-13-2025
- Dividend Yield
- ACXP N/A
- SXTP N/A
- EPS Growth
- ACXP N/A
- SXTP N/A
- EPS
- ACXP N/A
- SXTP N/A
- Revenue
- ACXP N/A
- SXTP $984,494.00
- Revenue This Year
- ACXP N/A
- SXTP $81.41
- Revenue Next Year
- ACXP N/A
- SXTP $83.17
- P/E Ratio
- ACXP N/A
- SXTP N/A
- Revenue Growth
- ACXP N/A
- SXTP 128.70
- 52 Week Low
- ACXP $3.80
- SXTP $1.22
- 52 Week High
- ACXP $39.20
- SXTP $12.45
- Technical
- Relative Strength Index (RSI)
- ACXP 54.01
- SXTP 45.37
- Support Level
- ACXP $6.24
- SXTP $1.43
- Resistance Level
- ACXP $6.80
- SXTP $1.52
- Average True Range (ATR)
- ACXP 0.61
- SXTP 0.13
- MACD
- ACXP -0.13
- SXTP -0.02
- Stochastic Oscillator
- ACXP 3.16
- SXTP 4.55
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.